title: [Long- and short-term survivors after chemotherapy among patients with advanced or recurrent gastric cancer in our hospital].
abstract: Since S-1 was approved in 1999, the response rate and the disease control rate of this chemotherapy for advanced or recurrent gastric cancer has been improved. Aa a result, we can plan for chemotherapy in patients with advanced or recurrent gastric cancer, because the median survival time (MST) with advanced or recurrent gastric cancer was over 20 months. We examined the characteristic findings of long- and short-term survivors in chemotherapy patients with advanced or recurrent gastric cancer. The prognosis for advanced gastric cancer is better than that for recurrent gastric cancer (p <0.02). In patients with only recurrent gastric cancer, the interval from surgery to recurrence is a significant prognostic factor. We thus show the results of chemotherapy for advanced or recurrent gastric cancer in our hospital and the characteristic findings in long- and short-term survivors for chemotherapy, and discuss effective planning of chemotherapy for each patient with advanced or recurrent gastric cancer.
authors.affiliation: Department of Surgery, Hiroshima Red-Cross Hospital and Atomic Bomb Survivors Hospital.
authors.forename: Manabu
authors.initials: M
authors.lastname: Yamamoto
authors.forename: Ayumi
authors.initials: A
authors.lastname: Matsuyama
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Kameyama
authors.forename: Masahiro
authors.initials: M
authors.lastname: Okamoto
authors.forename: Jin
authors.initials: J
authors.lastname: Okazaki
authors.forename: Tohru
authors.initials: T
authors.lastname: Utsunomiya
authors.forename: Shinichi
authors.initials: S
authors.lastname: Tsutsui
authors.forename: Teruyoshi
authors.initials: T
authors.lastname: Ishida
mesh_terms: D000368:Aged; D005260:Female; D006761:Hospitals; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012008:Recurrence; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D015996:Survival Rate; D013997:Time Factors